The promiscuity of the dopamine transporter: Implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes

Neuropharmacology

Volumn 53, Issue 8, 2007, Pages 982-989

  Norrholm, Seth D ^a,b,c   Horton, David B ^a   Dwoskin, Linda P ^a  

^a University of Kentucky   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Dopamine; Kinetics; Neurotransmitter transporter; Reuptake; Serotonin

Indexed keywords

DOPAMINE TRANSPORTER; FLUOXETINE; PAROXETINE; SEROTONIN; TRITIUM; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; KINETICS; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SYNAPTOSOME;

ANIMALS; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; HIPPOCAMPUS; MALE; PAROXETINE; PIPERAZINES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTOSOMES; TRITIUM;

EID: 36249023756     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.10.001     Document Type: Article

References (50)

1. 3H]serotonin into rat brain synaptosomes. Jpn. J. Pharmacol. 75 (1997) 123-128
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Callaghan P.D., Irvine R.J., and Daws L.C. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem. Int. 47 (2005) 350-361
4. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., and Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15 (1995) 1714-1723
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
6. Daws L.C., Toney G.M., Gerhardt G.A., and Frazer A. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J. Pharmacol. Exp. Ther. 286 (1998) 967-976
7. De Deurwaerdere P., Bonhomme N., Lucas G., Le Moal M., and Spampinato U. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J. Neurochem. 66 (1996) 210-215
8. 3H]mazindol autoradiography. Brain Res. 504 (1989) 64-71
9. 3H]serotonin reuptake in inbred rat strains. Endocr. Regul. 35 (2001) 119-126
10. Fernandez F., Sarre S., Launay J.-M., Aguerre S., Guyonnet-Duperat V., Moisan M.-P., Ebinger G., Michotte Y., Mormede P., and Chalouff F. Rat strain differences in peripheral and central serotonin transporter protein expression and function. Eur. J. Neurosci. 17 (2003) 494-506
11. Freed C., Revay R., Vaughan R.A., Kriek E., Grant S., Uhl G.R., and Kuhar M.J. Dopamine transporter immunoreactivity in rat brain. J. Comp. Neurol. 359 (1995) 340-349
12. Fuller R.W., Wong D.T., and Robertson D.W. Fluoxetine, a selective inhibitor of serotonin uptake. Med. Res. Rev. 11 (1991) 17-34
13. Fuxe K., Agnati L.F., Kalia M., Goldstein M., Andersson K., and Harfstrand A. Dopaminergic systems in the brain and pituitary. In: Fluckiger E., et al. (Ed). The Dopaminergic System (1985), Springer Sandoz, New York, NY 11-25
14. Graybiel A., and Ragsdale Jr. C.W. Biochemical anatomy of the striatum. In: Emson P.C. (Ed). Chemical Neuroanatomy (1983), Raven Press, New York 427-504
15. Hersch S.M., Yi H., Heilman C.J., Edwards R.H., and Levey A.I. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388 (1997) 211-227
16. 3H]5-hydroxytryptamine uptake in rat synaptosomes. Biochem. Pharmacol. 57 (1999) 111-120
17. Jackson B.P., and Wightman R.M. Dynamics of 5-hydroxytryptamine released from dopamine neurons in the caudate putamen of the rat. Brain Res. 674 (1995) 163-166
18. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-d-aspartic acid, glutamic acid and d-amphetamine. J. Pharmacol. Exp. Ther. 262 (1992) 356-364
19. Kirpekar S.M., and Wakade A.R. Factors influencing noradrenaline uptake by the perfused spleen of the cat. J. Physiol. 194 (1968) 609-626
20. Koch S., Perry K.W., Nelson D.L., Conway R.G., Threlkeld P.G., and Bymaster F.P. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27 (2002) 949-959
21. Kokoshka J.M., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R., and Fleckenstein A.E. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res. 799 (1998) 78-83
22. Lindmar R., and Loffelholz K. Differential effects of hypothemia on neuronal efflux, release and uptake of noradrenaline. Naunyn Schmiedeberg's Arch. Pharmacol. 274 (1972) 410-414
23. Martin C., Duclos M., Mormede P., Manier G., and Chaouloff F. Hippocampal and striatal [(3)H]5-HT reuptake under acute stressors in two rat strains differing for their emotivity. Neurosci. Lett. 288 (2000) 246-248
24. Matecka D., Lewis D.A., Rothman R.B., Dersch C.M., Wojnicki F.H.E., Glowa J.R., DeVries A.C., Pert A., and Rice K.C. Heteromeric analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis94-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR12935 and GBR12909) as high-affinity dopamine reuptake inhibitors. J. Med. Chem. 40 (1997) 705-716
25. 3H-GBR 12935. J. Neural Transm. Gen. Sect. 87 (1992) 1-14
26. Nandi A., Dersch C.M., Kulshrestha M., Ananthan S., and Rothman R.B. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter. Synapse 53 (2004) 176-183
27. Nemeroff C.B., and Owens M.J. Neuropharmacology of paroxetine. Psychopharmacol. Bull. 37 Suppl. 1 (2003) 8-18
28. Nightingale B., Dersch C.M., Boos T.L., Greiner E., Calhoun W.J., Jacobson A.E., Rice K.C., and Rothman R.B. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter. J. Pharmacol. Exp. Ther. 314 (2005) 906-915
29. 3H]serotonin into plasma membrane vesicles from mouse cerebral cortex. J. Biol. Chem. 263 (1988) 6115-6121
30. Owens M.J., Knight D.L., and Nemeroff C.B. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol. Psychiatry 50 (2001) 345-350
31. Pickel V.M., Nirenberg M.J., and Milner T.A. Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors. J. Neurocytol. 25 (1996) 843-856
32. Pollier F., Sarre S., Aguerre S., Ebinger G., Mormede P., Michotte Y., and Chaouloff F. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology 22 (2000) 64-76
33. Racca S., Spaccamiglio A., Esculapio P., Abbadessa G., Cangemi L., DiCarlo F., and Portaleone P. Effects of swim stress and alpha-MSH acute pre-treatment on brain 5-HT transporter and corticosterone receptor. Pharmacol. Biochem. Behav. 81 (2005) 894-900
34. Riddle E.L., Rau K.S., Topham M.K., Hanson G.R., and Fleckenstein A.E. Ceramide-induced alterations in dopamine transporter function. Eur. J. Pharmacol. 458 (2003) 31-36
35. 125I]RTI-55. J. Pharmacol. Exp. Ther. 270 (1994) 296-309
36. Rothman R.B., Mele A., Reid A.A., Akunne H., Greig N., Thurkauf A., Rice K.C., and Pert A. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development. FEBS Lett. 257 (1989) 341-344
37. Samuvel D.J., Jayanthi L.D., Bhat N.R., and Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J. Neurosci. 25 (2005) 29-41
38. Schroeter S., Apparsundaram S., Wiley R.G., Miner L.H., Sesack S.R., and Blakely R.D. Immunolocalization of the cocaine- and antidepressant-sensitive I-norepinephrine transporter. J. Comp. Neurol. 420 (2000) 211-232
39. Stamford J.A., Kruk Z.L., and Millar J. Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res. 515 (1990) 173-180
40. Suarez-Roca H., and Cubeddu L.X. The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals. J. Pharmacol. Exp. Ther. 302 (2002) 174-179
41. Swanson L.W., Kohler C., and Bjorkland A. The limbic region I: The septohippocampal system. In: Bjorkland A., et al. (Ed). Handbook of Chemical Neuroanatomy. Integrated Systems of the CNS, Part I vol. 5 (1987), Elsevier Science Publishing, New York, NY 125-177
42. Tao-Cheng J.H., and Zhou F.C. Differential polarization of serotonin transporters in axons versus soma-dendrites: an immunogold electron microscopy study. Neuroscience 94 (1999) 821-830
43. Vizi E.S. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem. Int. 33 (1998) 359-366
44. Wells G.B., Lopez M.C., and Tanaka J.C. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes. Brain Res. Bull. 48 (1999) 641-647
45. Zhang A., Zhou G., Hoepping A., Mukhopadhyaya J., Johnson K.M., Zhang M., and Kozikowski A.P. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)] decanes as a novel class of serotonin transporter inhibitors. J. Med. Chem. 45 (2002) 1930-1941
46. Zhou F.-M., Liang Y., Salas R., Zhang L., De Biasi M., and Dani J.A. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46 (2005) 65-74
47. Zhou F.C., Lesch K.P., and Murphy D.L. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res. 942 (2002) 109-119
48. Zhou F.C., Tao-Cheng J.H., Segu L., Patel T., and Wang Y. Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Res. 805 (1998) 241-254
49. Zhou M., Engel K., and Wang J. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem. Pharmacol. 73 (2007) 147-154
50. Zoli M., Jansson A., Sykova E., Agnati L.F., and Fuxe K. Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 20 (1999) 142-150